Status: Recruiting
The Impact of Phosphate Metabolism on Healthy Aging
Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial function), and cardiovascular function (echo- cardiography) in patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH) and patients with X-linked hypophosphatemia (XLH).
Participants needed: 30
Trial details
Phase: Early Phase 1Age: 13+Biological sex: AllType: InterventionalSponsor: Yale UniversityUpdated: May 27, 2026Locations: 1
Eligibility criteria
Children above the age of 13 years [+4]
Subjects will be excluded, if they are children younger than age 13 years [+4]